Novel immunolocalization of α-synuclein in human muscle of inclusion- body myositis, regenerating and necrotic muscle fibers, and at neuromuscular junctions

Journal of Neuropathology and Experimental Neurology

Volumn 59, Issue 7, 2000, Pages 592-598

  Askanas, Valerie ^a,b   Engel, W King ^a   Alvarez, Renate B ^a   McFerrin, Janis ^a   Broccolini, Aldobrando ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Cultured human muscle; Inclusion body myositis; Necrotic muscle fibers; Neuromuscular junctions; Regenerating muscle fibers; synuclein

Indexed keywords

ALPHA SYNUCLEIN; TAU PROTEIN;

ALZHEIMER DISEASE; CELL INCLUSION; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MUSCLE BIOPSY; MUSCLE NECROSIS; MUSCLE REGENERATION; MYOSITIS; NERVE DEGENERATION; NEUROMUSCULAR SYNAPSE; PAIRED HELICAL FILAMENT; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REVIEW;

EID: 0033934231     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/59.7.592     Document Type: Review

References (45)

1. Askanas V, Engel WK. Sporadic inclusion-body myositis and its similarities to Alzheimer disease brain. Recent approaches to diagnosis and pathogenesis, and relation to aging. Scand J Rheumatol 1998;27:389-405
2. Sarkozi E, Askanas V, Johnson SA, Engel WK, Alvarez RB. β-amyloid precursor protein mRNA is increased in inclusion-body myositis muscle. NeuroReport 1993;4:815-18
3. Mirabella M, Alvarez RB, Bilak M, Engel WK, Askanas V. Difference in expression of phosphorylated tau epitopes between sporadic inclusion-body myositis and hereditary inclusion-body myopathies. J Neuropathol Exp Neurol 1996;55:774-86
4. Askanas V, Engel WK, Alvarez RB. Light-and electronmicroscopic localization of β-amyloid protein in muscle biopsies of patients with inclusion-body myositis. Am J Pathol 1992;141:31-36
5. Goedert M, Jakes R, Spillantini MG. Alpha-synuclein and the Lewy body. Neurosci News 1998;1:47-52
6. Clayton DF, George JM. The synucleins: A family of proteins involved in synaptic function, plasticity, neurodegeneration and disease. Trends Neurosci 1998;21:249-54
7. Lavedan C. The synuclein family. Genome Res 1998;8:871-80
8. Goedert M, Spillantini MG, Davies SW. Filamentous nerve cell inclusions in neurodegenerative diseases. Curr Opin Neurobiol 1998;8:619-32
9. Farrer M, Gwinn-Hardy K, Hutton M, Hardy J. The genetics of disorders with synuclein pathology and parkinsonism. Hum Mol Genet 1999;8:1901-5
10. Spillantini MG, Schmidt ML, Lee VM-Y, Trojanowski JQ, Jakes R, Goedert M. γ-synuclein in Lewy bodies. Nature 1997;388:839-40
11. Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M. α-synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies. Proc Natl Acad Sci USA 1998;95:6469-73
12. Lippa CF, Fujiwara H, Mann DMA, et al. Lewy bodies contain altered α-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes. Am J Pathol 1998;153:1365-70
13. Takeda A, Mallory M, Sundsmo M, Honer W, Hansen L, Masliah E. Abnormal accumulation of NACP/α-synuclein in neurodegenerative disorders. Am J Pathol 1998;152:367-72
14. Tu P-H, Galvin JE, Baba M, et al. Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble α-synuclein. Ann Neurol 1998;44:415-22
15. Wakabayashi K, Yoshimoto M, Tsuji S, Takahashi H. α-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy. Neurosci Lett 1998;249:180-82
16. Gai WP, Power JH, Blumbergs PC, Blessing WW. Multiple-system atrophy: A new alpha-synuclein disease? Lancet 1998;352:547-48
17. Uéda K, Fukushima H, Masliah E, et al. Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proc Natl Acad Sci USA 1993;90:11282-86
18. Masliah E, Iwai A, Mallory M, Uéda K, Saitoh T. Altered presynaptic protein NACP is associated with plaque formation and neurodegeneration in Alzheimer's disease. Am J Pathol 1996;148:201-10
19. Newell KL, Boyer P, Gomez-Tortosa E, et al. α-synuclein immunoreactivity is present in axonal swelling in neuroaxonal dystrophy and acute traumatic brain injury. J Neuropathol Exp Neurol 1999;58:1263-68
20. Culvenor JG, McLean CA, Cutt S, et al. Non-Aβ component of Alzheimer's disease amyloid (NAC) revisited. NAC and α-synuclein are not associated with Aβ amyloid. Am J Pathol 1999;155: 1173-81
21. Engel WK. Muscle biopsies in neuromuscular diseases. Pediatr Clin N Am 1967;14:963-95
22. Engel WK, Cunningham GG. Rapid examination of muscle tissue-an improved trichrome method for fresh-frozen biopsy sections. Neurology 1963;13:919-23
23. Askanas V, Alvarez RB, Mirabella M, Engel WK. Use of anti-neurofilament antibody to identify paired-helical filaments in inclusion-body myositis. Ann Neurol 1996;39:389-91
24. Askanas V, Engel WK, Alvarez RB. Enhanced detection of Congo-red-positive amyloid deposits in muscle fibers of inclusion-body myositis and brain of Alzheimer disease using fluorescence technique. Neurology 1993;43:1265-67
25. Askanas V, Engel WK, Yang C-C, Alvarez RB. Lee VM-Y, Wisniewski T. Light and electron microscopic immunolocalization of Presenilin 1 in abnormal muscle fibers of patients with sporadic inclusion-body myositis and autosomal-recessive inclusion-body myopathy. Am J Pathol 1998;152:889-95
26. Yang C-C, Alvarez RB, Engel WK, Heller SL, Askanas V. Nitric-oxide induced oxidative stress in autosomal recessive and dominant inclusion-body myopathies. Brain 1998;121:1089-97
27. Yang C-C, Askanas V, Engel WK, Alvarez RB. Immunolocalization of transcription factor NF-κB in inclusion-body myositis muscle and at normal human neuromuscular junctions. Neurosci Lett 1998;254:77-80
28. Askanas V, Engel WK, Alvarez RB. Strong immunoreactivity of β-amyloid precursor protein, including the β-amyloid protein sequence, at human neuromuscular junctions. Neurosci Lett 1992;143:96-100
29. Askanas V, Engel WK. A technique of fiber selection from human muscle tissue cultures for histochemical-electronmicroscopic studies. J Histochem Cytochem 1975;23:144-46
30. Askanas V, Engel WK. Cultured normal and genetically abnormal human muscle. In: Rowland LP, DiMauro S, eds. The handbook of clinical neurology, myopathies. Amsterdam: North Holland, Vol 18, 1992:85-116
31. Askanas V. McFerrin J, Baqué S, Alvarez RB, Sarkozi E, Engel WK. Transfer of β-amyloid precursor protein gene using adenovirus vector causes mitochondrial abnormalities in cultured normal human muscle. Proc Natl Acad Sci USA 1996;93:1314-19
32. Askanas V, McFerrin J, Alvarez RB, Baqué S, Engel WK. βAPP gene transfer into cultured human muscle induces inclusion-body myositis aspects. NeuroReport 1997;8:2155-58
33. Jakes R, Spillantini MG, Goedert M. Identification of two distinct synucleins from human brain. FEBS Lett 1994;345:27-32
34. George JM, Jin H, Woods WS, Clayton DF. Characterization of a novel protein regulated during the critical period for song learning in the zebra finch. Neuron 1995;15:361-72
35. Jensen PH, Sørensen ES, Petersen TE, Gliemann J, Rasmussen LK. Residues in the synuclein consensus motif of the α-synuclein fragment, NAC, participate in transglutaminase-catalysed cross-linking to Alzheimer-disease amyloid βA4 peptide. Biochem J 1995;310: 91-94
36. Jensen PH, Højrup P, Hager H, et al. Binding of Aβ to α-and β-synucleins: Identification of segments in α-synuclein/NAC precursor that bind Aβ and NAC. Biochem J 1997;323:539-46
37. Yoshimoto M, Iwai A, Kang D, Otero DAC, Xia Y, Saitoh T. NACP. the precursor of non-amyloid β/A4 protein (Aβ) component of Alzheimer disease amyloid, binds Aβ and stimulates Aβ aggregation. Proc Natl Acad Sci USA 1995;92:9141-45
38. Iwai A, Yoshimoto M, Masliah E, Saitoh T. Non-Aβ component of Alzheimer's disease amyloid (NAC) is amyloidogenic. Biochemistry 1995;34:10139-45
39. Hashimoto M, Hsu LJ, Sisk A, et al. Human recombinant NACP/ α-synuclein is aggregated and fibrillated in vitro: Relevance for Lewy body disease. Brain Res 1998;799:301-6
40. Han H, Weinreb PH, Lansbury Jr, PT. The core Alzheimer's peptide NAC forms amyloid fibrils which seed and are seeded by β-amyloid: Is NAC a common trigger or target in neurodegenerative disease? Chem Biol 1995;2:163-69
41. Lee J-H, Shin H-J, Chang C-S, Paik SR. Comparisons of the NACP self-oligomerizations induced by Aβ25-35 in the presence of dicyclohexylcarbodiimide and N-(ethoxycarbonyl)-2-ethoxy-1,2-dihydroquinoline. Neurochem Res 1998;23:1427-34
42. Hashimoto M, Hsu LJ, Xia Y, et al. Oxidative stress induces amyloid-like aggregate formation of NACP/alpha-synuclein in vitro. NeuroReport 1999;10:717-21
43. Askanas V, Engel WK. Sporadic inclusion-body myositis and hereditary inclusion-body myopathies. Diseases of oxidative stress and aging? Arch Neurol 1998;55:915-20
44. Hashimoto M, Yoshimoto M, Sisk A, et al. NACP, a synaptic protein involved in Alzheimer's disease, is differentially regulated during megakaryocyte differentiation. Biochem Biophys Res Comm 1997;237:611-16
45. McFerrin J, Engel WK, Askanas V. Impaired innervation of cultured human muscle overexpressing βAPP experimentally and genetically: Relevance to inclusion-body myopathies. NeuroReport 1998;9:3201-5